Integrated R&D Campus
Hyderabad, India
Sai Life Sciences’ 12-acre Integrated R&D Campus in Hyderabad brings together discovery science, development expertise, and early-phase manufacturing within a single connected environment. The campus is designed to support programs from early target discovery through development and early clinical supply, enabling seamless progression across disciplines.
Advanced infrastructure, specialized technology platforms, and experienced scientific teams enable close collaboration across discovery and development activities, accelerating decision-making and translation of scientific insights into development-ready processes.
Site Highlights
12-acre integrated R&D campus
enabling seamless progression from discovery and development to GMP-aligned early clinical supply, manufacturing and research.
Dedicated biology and translational sciences building
supporting ADME, in-vitro toxicology, and automated workflows
Structure‑enabled drug discovery
Advanced computational and structure-enabled drug discovery center
Platform technology capabilities
including biocatalysis, chemo‑catalysis, flow chemistry, and particle engineering enabling efficient, scalable development.
Fully equipped Process Safety Laboratory
for evaluating thermal and reaction hazards to enable safe process development and scale‑up.
Integrated early-phase GMP manufacturing facility
supporting rapid, compliant transition from development to clinical supply.
Site Highlights
12-acre integrated R&D campus
Dedicated biology and translational sciences building
Structure‑enabled drug discovery
Platform technology capabilities
Fully equipped Process Safety Laboratory
Integrated early-phase GMP manufacturing facility
Site Capabilities
The Hyderabad campus provides integrated discovery and development capabilities supporting programs across small molecules and emerging modalities. Scientific teams collaborate across disciplines to advance programs efficiently from early research through development and clinical supply.
Discovery
From target ID & validation to IND Stage through Creative Chemistry, Complex Biology, DMPK & Toxicology.
- Integrated Drug Discovery
- Complex Chemical Synthesis
- In vitro and in vivo pharmacology
- Comprehensive ADME and PK profiling
- Toxicology evaluation
Development
Advanced chemical synthesis and process development enabling scale‑up to commercial production.
- Advanced labs for early, late phase and commercial delivery
- Comprehensive analytical capabilities
- Fully equipped process safety lab
- Pilot plant and early phase delivery block
- HPAPI (< 0.1µg/m3) capability
- Technology platforms – Bio catalysis, Flow chemistry, Chemo catalysis, Continuous extraction, Continuous distillation
Scale-up & Clinical Supplies
Rapid, flexible production of clinical trial materials to support preclinical and early‑stage (Phase I/II) development.
- GMP manufacturing for preclinical and First-in-Human programs
- Early clinical supply up to ~25 kg scale with advanced reactor infrastructure
Discovery
From target ID & validation to IND Stage through Creative Chemistry, Complex Biology, DMPK & Toxicology.
Development
Advanced chemical synthesis and process development enabling scale‑up to commercial production.
Scale-up & Clinical Supplies
Rapid, flexible production of clinical trial materials to support preclinical and early‑stage (Phase I/II) development.
- Integrated Drug Discovery
- Complex Chemical Synthesis
- In vitro and in vivo pharmacology
- Comprehensive ADME and PK profiling
- Toxicology evaluation
- Advanced labs for early, late phase and commercial delivery
- Comprehensive analytical capabilities
- Fully equipped process safety lab
- Pilot plant and early phase delivery block
- HPAPI (< 0.1µg/m3) capability
- Technology platforms – Bio catalysis, Flow chemistry, Chemo catalysis, Continuous extraction, Continuous distillation
- GMP manufacturing for preclinical and First-in-Human programs
- Early clinical supply up to ~25 kg scale with advanced reactor infrastructure
The Hyderabad Advantage
Located in the thriving life sciences hub of Hyderabad, Sai Life Sciences’ Integrated R&D Campus benefits from one of India’s most dynamic innovation ecosystems. The city brings together a strong concentration of global pharma and biotech companies, leading research institutions, skilled scientific talent, and robust infrastructure that accelerates collaboration and discovery. Supported by a progressive industrial environment and strong connectivity, Hyderabad has emerged as a preferred destination for drug discovery and development. This vibrant ecosystem enables Sai Life Sciences to seamlessly integrate science, technology, and talent — helping innovators advance programs with greater speed, agility, and confidence.
Testimonials
Resources
Inside Sai Life Sciences’ Integrated R&D Campus: Accelerating Drug Development
In a recent feature published in R&D World, Sai Life Sciences’ Integrated R&D Campus in Hyderabad is showcased as a […]
AI-driven retrosynthesis integrated into Discovery Chemistry
Sai Life Sciences has entered into a collaboration with Chemical.AI, a technology company specialising in computer-aided synthesis design, to integrate […]
Structural Biology capabilities launched with X-Ray Crystallography
Sai Life Sciences has introduced integrated structural biology capabilities with the establishment of X-ray protein crystallography workflows to support structure-based […]